Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Croucher

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|February 26, 2024
Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancerXue Yang, Xiuquan Ma, Tianyue Zhao, et al.
Breast Cancer Research : BCR|March 23, 2019
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancerSean P Kennedy, Jeremy Z R Han, Neil Portman, et al.
Cancers|October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate CancerHui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
Cancer & Metabolism|January 16, 2022
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnoverNikki L Raftopulos, Tinashe C Washaya, Andreas Niederprüm, et al.
Oncogene|May 11, 2018
MASTL overexpression promotes chromosome instability and metastasis in breast cancerSamuel Rogers, Rachael A McCloy, Benjamin L Parker, et al.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
Cell Reports|June 14, 2018
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic CancerJames R W Conway, Sean C Warren, David Herrmann, et al.
The Journal of Experimental Medicine|March 21, 2023
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2Tina Nguyen, Anthony Lau, Julia Bier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteinsChristopher R Horne, Toby A Dite, Samuel N Young, et al.
Nature Communications|August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasisMichael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|February 26, 2024
Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancerXue Yang, Xiuquan Ma, Tianyue Zhao, et al.
Breast Cancer Research : BCR|March 23, 2019
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancerSean P Kennedy, Jeremy Z R Han, Neil Portman, et al.
Cancers|October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate CancerHui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
Cancer & Metabolism|January 16, 2022
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnoverNikki L Raftopulos, Tinashe C Washaya, Andreas Niederprüm, et al.
Oncogene|May 11, 2018
MASTL overexpression promotes chromosome instability and metastasis in breast cancerSamuel Rogers, Rachael A McCloy, Benjamin L Parker, et al.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
Cell Reports|June 14, 2018
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic CancerJames R W Conway, Sean C Warren, David Herrmann, et al.
The Journal of Experimental Medicine|March 21, 2023
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2Tina Nguyen, Anthony Lau, Julia Bier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteinsChristopher R Horne, Toby A Dite, Samuel N Young, et al.
Nature Communications|August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasisMichael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Pageof 6